National Comprehensive Cancer Network



About NCCN

Myelodysplastic Syndromes Panel - Disclosures as of 5/22/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Aref Al-Kali, MD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
MedImmune Inc.;
Novartis Pharmaceuticals Corporation;
Ambit;
Onconova

None

None

None

None

2/10/2015

Stefan K. Barta, MD, MS, MRCP

Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Seatttle Genetics;
Spectrum Pharmaceuticals

Seattle Genetics

Celgene Corporation;
Seattle Genetics;
Pharmacyclics

None

None

3/31/2015

Rafael Bejar, MD, PhD

None

Celgene Corporation;
Genoptix

Genoptix

Genoptix

None

2/9/2015

John M. Bennett, MD

None

Amgen Inc.;
Onconova

None

Celgene Corporation

None

2/19/2015

Marian Birkeland, PhD

None

None

None

None

None

4/13/2015

Clara D. Bloomfield, MD

None

None

None

None

None

2/9/2015

Uma Borate, MD

Eli Lilly and Company;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Seattle Genetics;
Pfizer Inc.

Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.

None

None

1/29/2015

Carlos M. De Castro, MD

MethylGene

None

None

None

None

1/27/2015

H. Joachim Deeg, MD

Medac;
Medac

Medac

None

None

None

1/21/2015

Amy E. DeZern, MD, MHS

None

None

None

None

None

1/20/2015

Amir T. Fathi, MD

None

Agios Pharmaceuticals;
Ariad Pharmaceuticals;
Seattle Genetics

None

None

None

1/20/2015

Olga Frankfurt, MD

None

None

None

None

None

1/8/2015

Karin Gaensler, MD

None

None

None

None

None

1/20/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Guillermo Garcia-Manero, MD

Celgene Corporation;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

2/9/2015

Peter L. Greenberg, MD

GlaxoSmithKline;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
KaloBios, Inc;
Onconova;
Tetralogic

Novartis Pharmaceuticals Corporation

None

None

None

2/22/2015

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

4/15/2015

Elizabeth A. Griffiths, MD

Astex Pharmaceuticals

Alexion Pharmaceuticals, Inc.;
ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Astex Pharmaceuticals;
Incyte

Alexion Pharmaceuticals, Inc.;
Celgene Corporation

None

None

11/21/2014

David Head, MD

None

None

None

None

None

2/9/2015

Virginia M. Klimek, MD

Karyopharm;
MSKCC DSMC

Sunesis Pharmaceuticals, Inc.

None

None

None

1/20/2015

Rami Komrokji, MD

Celgene Corporation;
GlaxoSmithKline;
Incyte;
Onconova

Celgene Corporation;
Incyte

Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Incyte

None

None

2/9/2015

Lisa A. Kujawski, MD

None

None

None

None

None

4/13/2015

Lori J. Maness, MD

None

None

None

None

None

4/10/2015

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Margaret R. O'Donnell, MD

National Cancer Institute

Sunesis Pharmaceuticals, Inc.

None

None

None

4/10/2015

Daniel A. Pollyea, MD, MS

Celgene Corporation;
Abbvie;
Agios;
GlycoMimetics;
Pfizer Inc.

Celgene Corporation;
Agios;
Karyopharm;
Pfizer Inc.

None

None

None

5/18/2015

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

4/6/2015

Paul J. Shami, MD

Amgen Inc.;
ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Genzyme Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Cantex Pharmaceuticals;
Seattle Genetics;
Tetralogic;
Pfizer Inc.;
Roche Laboratories, Inc.

Incyte

None

None

None

4/13/2015

Dorothy Shead, MS

None

None

None

None

None

2/18/2015

Courtney Smith, PhD

None

None

None

Johnson & Johnson;
OPKO

Ethos Health Communications, Complete Healthcare Communications

5/13/2015

Brady L. Stein, MD, MHS

Incyte Corporatation;
NS-Pharma

UBC Late Stage

Incyte Corporation

None

None

4/6/2015

Richard M. Stone, MD

Celgene Corporation;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Abbvie;
Agios;
Celator;
Juno;
Seattle Genetics;
Xenetic;
Roche Laboratories, Inc.;
Sunesis Pharmaceuticals, Inc.

None

None

4/6/2015

Sarika Trikha, PharmD

None

None

None

None

None

4/13/2015

Peter Westervelt, MD, PhD

None

None

None

None

None

2/23/2015

Benton Wheeler, MD

None

None

None

None

None

1/30/2015

Amer Zeidan, MBBS, MHS

None

ARIAD Pharmaceuticals, Inc.;
Boehringer Ingelheim GmbH

None

None

None

4/1/2015